CA2511440A1 - Reduction of reactive oxygen species in chronic wound management - Google Patents

Reduction of reactive oxygen species in chronic wound management Download PDF

Info

Publication number
CA2511440A1
CA2511440A1 CA002511440A CA2511440A CA2511440A1 CA 2511440 A1 CA2511440 A1 CA 2511440A1 CA 002511440 A CA002511440 A CA 002511440A CA 2511440 A CA2511440 A CA 2511440A CA 2511440 A1 CA2511440 A1 CA 2511440A1
Authority
CA
Canada
Prior art keywords
solution
ions
wound
weight
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002511440A
Other languages
English (en)
French (fr)
Inventor
Stephen H. Monroe
Hans Hoekstra
A. J. J. Van Den Berg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GREYSTONE PHARMACEUTICALS Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2511440A1 publication Critical patent/CA2511440A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
CA002511440A 2002-12-23 2003-12-23 Reduction of reactive oxygen species in chronic wound management Abandoned CA2511440A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43619702P 2002-12-23 2002-12-23
US60/436,197 2002-12-23
PCT/US2003/041038 WO2004057965A1 (en) 2002-12-23 2003-12-23 Reduction of reactive oxygen species in chronic wound management

Publications (1)

Publication Number Publication Date
CA2511440A1 true CA2511440A1 (en) 2004-07-15

Family

ID=32682357

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002511440A Abandoned CA2511440A1 (en) 2002-12-23 2003-12-23 Reduction of reactive oxygen species in chronic wound management

Country Status (6)

Country Link
EP (1) EP1575359A4 (cg-RX-API-DMAC7.html)
JP (1) JP2006511585A (cg-RX-API-DMAC7.html)
CN (1) CN1744819A (cg-RX-API-DMAC7.html)
AU (1) AU2003303335A1 (cg-RX-API-DMAC7.html)
CA (1) CA2511440A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004057965A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009251711B2 (en) * 2008-04-01 2014-07-17 Antipodean Pharmaceuticals, Inc. Compositions and methods for skin care
WO2011022757A1 (en) * 2009-08-24 2011-03-03 Queensland University Of Technology Purine-targeted diagnosis and therapy of wounds
WO2013016255A1 (en) * 2011-07-28 2013-01-31 3M Innovative Properties Company Wound-healing compositions and method of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3416777C2 (de) * 1984-05-07 1986-11-20 Gödecke AG, 1000 Berlin Pharmazeutische topische Zubereitungen
DK0668769T3 (da) * 1992-11-06 2000-10-02 Greystone Medical Group Inc Egebarkekstrakt-relaterede syntetiske sammensætninger og fremgangsmåde til deres anvendelse
NZ533252A (en) * 2001-11-29 2006-03-31 Greystone Medical Group Inc Treatment of wounds and compositions employed

Also Published As

Publication number Publication date
EP1575359A4 (en) 2009-08-05
JP2006511585A (ja) 2006-04-06
CN1744819A (zh) 2006-03-08
EP1575359A1 (en) 2005-09-21
AU2003303335A1 (en) 2004-07-22
WO2004057965A1 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
US20080220091A1 (en) Reduction of reactive oxygen species in chronic wound management
Rotruck et al. Prevention of oxidative damage to rat erythrocytes by dietary selenium
Varma Scientific basis for medical therapy of cataracts by antioxidants
Haraguchi et al. Protection against oxidative damage by dihydroflavonols in Engelhardtia chrysolepis
Ferrari et al. Occurrence of oxidative stress during myocardial reperfusion
Kulkarni et al. Studies on biochemical changes with special reference to oxidant and antioxidants in malaria patients
Varma et al. Prevention of oxidative damage to rat lens by pyruvate in vitro: possible attenuation in vivo
KONUKOGLU et al. Antioxidant status in experimental peritonitis: effects of alpha tocopherol and taurolin
Abubakar et al. Regional accumulation of aluminium in the rat brain is affected by dietary vitamin E
Fantozzi et al. FMLP-activated neutrophils evoke histamine release from mast cells
EP1173255A2 (en) Use of pirenoxine for the protection of corneal tissues in photokeratectomy
Gay et al. Differential inhibition of neutrophil superoxide generation by nonsteroidal antiinflammatory drugs
Boros et al. Oxygen free radical-induced histamine release during intestinal ischemia and reperfusion
Kim et al. Effect of select antioxidants on malondialdehyde modification of proteins
Gamaley et al. Activation of murine macrophages by hydrogen peroxide
Al-Moutairy et al. Effect of vitamin E and selenium on hypothermic restraint stress and chemically-induced ulcers
AU2003303335A1 (en) Reduction of reactive oxygen species in chronic wound management
Shvedova et al. Lipid peroxidation and electric activity of the retina
Khatami et al. Ascorbate regeneration in bovine ocular tissues by NADH-dependent semidehydroascorbate reductase
Rossi et al. O2− and H2O2 production during the respiratory burst in alveolar macrophages
Garcı́a-González et al. Anti-inflammatory activity of Debaryomyces hansenii Cu, Zn-SOD
WO1990013290A1 (fr) Composition pharmaceutique a base de paracetamol
Doni et al. High glutathione peroxidase and prostacyclin-like activity generation in rat aorta
Okabe et al. Free radical damage to sarcoplasmic reticulum of masseter muscle by arachidonic acid and prostaglandin G2
Nishiwaki et al. Ulcerogenic and healing impairing actions of monochloramine in rat stomachs: effects of zinc L-carnosine, polaprezinc

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead